Skip to main content
Novel radiotracer shows promise in assessing prostate cancer
10/11/2017

PET/CT with Ga-68-THP-PSMA, a radiotracer developed by King's College London graduate student Jennifer Young, provided increased imaging sensitivity in diagnosing patients with prostate cancer, and the tracer's low cost and easy production process may lead to increased PET/CT access for these patients, researchers reported in the Journal of Nuclear Medicine. Theragnostics CEO Greg Mullen, who was among those who oversaw Young's work, said the company is advancing the tracer's clinical development and "working with regulatory bodies to address an unmet clinical need by bringing this technology to prostate cancer patients."

Full Story: